Figure 4.
CWA-sTF/FIXa in patients with acute cerebral infarction treated with argatroban and anti-platelet agents (A), direct oral anticoagulant (B), heparin (C), or anti-platelet agents (D). CWA, clot wave form; stf/FIXa, small amount of tissue factor-induced FIX activation; navy line, fibrin formation curve; FFH, fibrin formation height; pink line, first derivative curve (velocity); 1stDPH, first derivative peak height; light blue, second derivative curve (acceleration); second DPH, second derivative peak height; solid line, patient; dotted line, healthy volunteer. The peak times of (A) and (B) are longer for the solid line (patient) than for the dotted line (healthy volunteer). The peak height of (A) and (B) is slightly and of that of (B)-(D) higher for the solid line (patient) than for the dotted line (healthy volunteer).